Understanding Overdiagnosis in Breast Cancer Screening
Author Information
Author(s): Duffy S W, Lynge E, Jonsson H, Ayyaz S, Olsen A H
Primary Institution: Cancer Research UK Centre for Epidemiology Mathematics and Statistics
Hypothesis
How does screening for breast cancer affect the estimation of overdiagnosis?
Conclusion
The study suggests that complexities in interpreting breast cancer incidence data may account for much of the observed increases in incidence, rather than overdiagnosis alone.
Supporting Evidence
- Breast cancer incidence increased in many countries before screening was introduced.
- Lead time effects can inflate observed incidence rates.
- Changes in hormone replacement therapy use may also affect incidence rates.
Takeaway
When doctors look for breast cancer using screening, they sometimes find cancers that wouldn't have caused any problems. This study helps explain why the numbers of cancer cases can look higher than they really are.
Methodology
The study analyzes breast cancer incidence data from Sweden and discusses the complexities introduced by screening.
Potential Biases
Potential overinterpretation of incidence patterns as overdiagnosis.
Limitations
The estimates of overdiagnosis rely on several assumptions and do not include all types of breast cancer.
Participant Demographics
Women aged 50-59 in Sweden.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website